Utah plans to allow an AI product to evaluate patients and write new drug prescriptions without prior human review.
Vaxcyte disclosed that its pneumococcal vaccine hit the primary endpoints in a Phase 3 clinical trial, setting up a ...
It is probably impossible to overstate how complex a brain is: A network of billions of intertwined neurons forming an ...
The Trump administration released new regulations Monday that will force health insurance companies to publish cleaned-up spreadsheets of the prices that they pay hospitals and do ...
Vaxcyte said its experimental pneumococcal vaccine hit the primary endpoints in a Phase 3 clinical trial, setting up the ...
What science says so far about which cancers can be beat by vaccines — and which will require more creative approaches.
Merck discontinued Recarbio, an important antibiotic in the U.S., despite concerns over resistance to superbugs.
The small biotech company Invivyd is developing an injectable, low-dose monoclonal antibody to protect against Covid.
Ahead of this year's Nobel Prize announcements, STAT chatted with Mary-Claire King, who discovered the BRCA cancer mutations ...
President Trump is promising more payments to voters just ahead of the Nov. 3 midterm elections — this time for seniors' Medicare Part B premiums ...
Congo's Ebola outbreak has killed more than 4,000 people, authorities said, as they struggle to contain what has become the ...
Hundreds of thousands of immigrants with legal status, including refugees and sex-trafficking victims, are at risk of losing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results